Terms: = Endocrine gland cancer AND CCNE1, CCNE, 898, ENSG00000105173, P24864
218 results:
1. Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations.
Liu D; Cao M; Wang H; Cao W; Zheng C; Li Y; Wang Y
BMC Med; 2024 Mar; 22(1):137. PubMed ID: 38528540
[TBL] [Abstract] [Full Text] [Related]
2. Survival time prediction in patients with high-grade serous ovarian cancer based on
He D; Zhang X; Chang Z; Liu Z; Li B
BMC Cancer; 2024 Mar; 24(1):337. PubMed ID: 38475819
[TBL] [Abstract] [Full Text] [Related]
3. Value of diffusion kurtosis MR imaging and conventional diffusion weighed imaging for evaluating response to first-line chemotherapy in unresectable pancreatic cancer.
Zhang Z; Zhang Y; Hu F; Xie T; Liu W; Xiang H; Li X; Chen L; Zhou Z
Cancer Imaging; 2024 Feb; 24(1):29. PubMed ID: 38409049
[TBL] [Abstract] [Full Text] [Related]
4. Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
Chien YW; Wang Y; Huang P; Lawson BC; Kolin DL; Chui MH; Vang R; Numan TA; Soong TR; Wang BG; Smith SA; Chen CL; Stone R; Douville C; Wang TL; Shih IM
Am J Surg Pathol; 2024 Apr; 48(4):475-486. PubMed ID: 38298022
[TBL] [Abstract] [Full Text] [Related]
5. Compartment-specific multiomic profiling identifies SRC and GNAS as candidate drivers of epithelial-to-mesenchymal transition in ovarian carcinosarcoma.
Herrington CS; Oswald AJ; Stillie LJ; Croy I; Churchman M; Hollis RL
Br J Cancer; 2024 Feb; 130(2):327-335. PubMed ID: 38097740
[TBL] [Abstract] [Full Text] [Related]
6. Aneuploidy Landscape in Precursors of Ovarian cancer.
Wang Y; Douville C; Chien YW; Wang BG; Chen CL; Pinto A; Smith SA; Drapkin R; Chui MH; Numan T; Vang R; Papadopoulos N; Wang TL; Shih IM
Clin Cancer Res; 2024 Feb; 30(3):600-615. PubMed ID: 38048050
[TBL] [Abstract] [Full Text] [Related]
7. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian cancer.
Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
[TBL] [Abstract] [Full Text] [Related]
8. Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid cancer: Updated Efficacy and Safety Data from the ARROW Study.
Subbiah V; Hu MI; Mansfield AS; Taylor MH; Schuler M; Zhu VW; Hadoux J; Curigliano G; Wirth L; Gainor JF; Alonso G; Adkins D; Godbert Y; Ahn MJ; Cassier PA; Cho BC; Lin CC; Zalutskaya A; Barata T; Trask P; Scalori A; Bordogna W; Heinzmann S; Brose MS
Thyroid; 2024 Jan; 34(1):26-40. PubMed ID: 38009200
[No Abstract] [Full Text] [Related]
9. [Efficacy and feasibility of catheter-based adrenal ablation on Cushing's syndrome associated hypertension].
Yan ZC; Jiang N; Zhang HX; Zhou Q; Liu XL; Sun F; Yang RM; He HB; Zhao ZG; Zhu ZM
Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Nov; 51(11):1152-1159. PubMed ID: 37963750
[No Abstract] [Full Text] [Related]
10. Clinical predictors and significance of adherent periadrenal fat in laparoscopic adrenalectomy.
Olcucuoglu E; Senel S; Uzun E; Ceviz K; Gultekin H; Arabaci HB; Koudonas A; Aydin C
BMC Urol; 2023 Nov; 23(1):176. PubMed ID: 37915035
[TBL] [Abstract] [Full Text] [Related]
11. Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.
Köbel M; Yang RZ; Kang EY; Al-Shamma Z; Cook LS; Kinloch M; Carey MS; Hopkins L; Nelson GS; McManus KJ; Vizeacoumar FS; Vizeacoumar FJ; Freywald A; Fu Y; Reuss DE; Lee CH
Gynecol Oncol; 2023 Nov; 178():80-88. PubMed ID: 37820398
[TBL] [Abstract] [Full Text] [Related]
12. Development and validation of a nomogram for risk of pulmonary metastasis in non-papillary thyroid carcinoma: A SEER-based study.
Li Y; Gao X; Guo T; Liu J
Medicine (Baltimore); 2023 Aug; 102(32):e34581. PubMed ID: 37565907
[TBL] [Abstract] [Full Text] [Related]
13. D898_E901
Porcelli T; Moccia M; De Stefano MA; Ambrosio R; Capoluongo E; Santoro M; Hadoux J; Schlumberger M; Carlomagno F; Salvatore D
JCO Precis Oncol; 2023 Aug; 7():e2300052. PubMed ID: 37535881
[TBL] [Abstract] [Full Text] [Related]
14. Subcellular localization of nucleolar protein 14 and its proliferative function mediated by miR-17-5p and E2F4 in pancreatic cancer.
Du YX; Zhou Y; Zheng XH; Duan YJ; Gu ZT; Yin YF; Wang CF
Aging (Albany NY); 2023 Jul; 15(14):7308-7323. PubMed ID: 37506248
[TBL] [Abstract] [Full Text] [Related]
15. The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma.
Smith P; Bradley T; Gavarró LM; Goranova T; Ennis DP; Mirza HB; De Silva D; Piskorz AM; Sauer CM; Al-Khalidi S; Funingana IG; Reinius MAV; Giannone G; Lewsley LA; Stobo J; McQueen J; Bryson G; Eldridge M; ; Macintyre G; Markowetz F; Brenton JD; McNeish IA
Nat Commun; 2023 Jul; 14(1):4387. PubMed ID: 37474499
[TBL] [Abstract] [Full Text] [Related]
16.
Gupta N; Huang TT; Nair JR; An D; Zurcher G; Lampert EJ; McCoy A; Cimino-Mathews A; Swisher EM; Radke MR; Lockwood CM; Reichel JB; Chiang CY; Wilson KM; Cheng KC; Nousome D; Lee JM
Sci Transl Med; 2023 Jun; 15(701):eadd7872. PubMed ID: 37343085
[TBL] [Abstract] [Full Text] [Related]
17. A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors.
Bauer TM; Moore KN; Rader JS; Simpkins F; Mita AC; Beck JT; Hart L; Chu Q; Oza A; Tinker AV; Imedio ER; Kumar S; Mugundu G; Jenkins S; Chmielecki J; Jones S; Spigel D; Fu S
Target Oncol; 2023 Jul; 18(4):517-530. PubMed ID: 37278879
[TBL] [Abstract] [Full Text] [Related]
18. WEE1 inhibitor adavosertib in combination with carboplatin in advanced TP53 mutated ovarian cancer: A biomarker-enriched phase II study.
Embaby A; Kutzera J; Geenen JJ; Pluim D; Hofland I; Sanders J; Lopez-Yurda M; Beijnen JH; Huitema ADR; Witteveen PO; Steeghs N; van Haaften G; van Vugt MATM; de Ridder J; Opdam FL
Gynecol Oncol; 2023 Jul; 174():239-246. PubMed ID: 37236033
[TBL] [Abstract] [Full Text] [Related]
19. Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes.
Cunnea P; Curry EW; Christie EL; Nixon K; Kwok CH; Pandey A; Wulandari R; Thol K; Ploski J; Morera-Albert C; McQuaid S; Lozano-Kuehne J; Clark JJ; Krell J; Stronach EA; McNeish IA; Bowtell DDL; Fotopoulou C
Cell Rep Med; 2023 Jun; 4(6):101055. PubMed ID: 37220750
[TBL] [Abstract] [Full Text] [Related]
20. Machine learning prediction of venous thromboembolism after surgeries of major sellar region tumors.
Qiao N; Zhang Q; Chen L; He W; Ma Z; Ye Z; He M; Zhang Z; Zhou X; Shen M; Shou X; Cao X; Wang Y; Zhao Y
Thromb Res; 2023 Jun; 226():1-8. PubMed ID: 37079979
[TBL] [Abstract] [Full Text] [Related]
[Next]